Status:

COMPLETED

Cardiometabolic Outcomes With Light Exposure During Sleep

Lead Sponsor:

Northwestern University

Conditions:

Light

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

This study tested the hypothesis that acute exposure to light during nighttime sleep adversely affects cardiometabolic function.

Detailed Description

This study tested the hypothesis that acute exposure to light during sleep adversely affects next morning glucose homeostasis and whether this effect occurs via reduced sleep quality, melatonin suppre...

Eligibility Criteria

Inclusion

  • healthy adults
  • ages 18-40 years
  • habitual sleep duration of 6.5-8.5 hours
  • habitual sleep onset of 9:00 pm-1:00 am

Exclusion

  • any sleep disorder as assessed by history and screening questionnaires for obstructive sleep apnea (Berlin) and excessive daytime sleepiness (ESS \>12), and by PSG to exclude sleep apnea (apnea hypopnea index ≥ 15), periodic leg movements (movement arousal index ≥ 15), or REM sleep behavior disorder;
  • history of a cognitive or neurological disorder;
  • history of a major psychiatric disorder, including but not limited to mood/anxiety, eating, and alcohol/substance abuse disorders;
  • depressed mood (Beck Depression Inventory II score ≥ 20);
  • diabetes or other endocrine disorders;
  • any gastrointestinal disease requiring dietary adjustment;
  • blindness or significant vision loss;
  • any unstable or serious medical conditions;
  • current or recent (within the past month) of psychoactive, hypnotic, stimulant or analgesic medications;
  • shift work or other types of self-imposed irregular sleep schedules;
  • obesity (body mass index \> 30 kg/m2);
  • history of habitual smoking (6 or more cigarettes per week) or drinking (7 or more alcoholic beverages per week) or caffeine consumption greater than 300 mg per day;
  • current use of light therapy;
  • use of any other legal or illicit substance that may affect sleep and/or appetite;
  • allergy to heparin.
  • Due to the metabolic stress associated with pregnancy and breastfeeding, patients who were pregnant or breastfeeding were also excluded.

Key Trial Info

Start Date :

February 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05317559

Start Date

February 1 2014

End Date

July 1 2018

Last Update

April 8 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.